NEW YORK (GenomeWeb) – SenzaGen announced today that it has signed an agreement under which its GARD skin allergy tests will be marketed worldwide by contract research organization Eurofins BioPharma Product Testing Munich (Eurofins BPT Munich).
...and receive Daily News bulletins.
Already have an account?Login Now.
In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."
Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.
Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.
In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.